Literature DB >> 6379681

Heparin and the atherosclerotic process.

H Engelberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6379681

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN： 0031-6997            Impact factor:   25.468


× No keyword cloud information.
  5 in total

Review 1.  Cell culture systems to study progression and inhibition of intimal proliferations.

Authors:  E Betz
Journal:  Basic Res Cardiol       Date:  1991 Mar-Apr       Impact factor: 17.165

2.  Treatment of vasculitis with chlorpromazine and dapsone.

Authors:  S S Asghar; W Westerhof; P K Das; F C Jansen; R H Cormane
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

3.  Salubrious effect of low molecular weight heparin on atherogenic diet-induced cardiac, hepatic and renal lipid peroxidation and collapse of antioxidant defences.

Authors:  P R Deepa; P Varalakshmi
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

4.  Inhibition of leucocyte elastase by heparin and its derivatives.

Authors:  F Redini; J M Tixier; M Petitou; J Choay; L Robert; W Hornebeck
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

Review 5.  Aerosols for systemic treatment.

Authors:  D Köhler
Journal:  Lung       Date:  1990       Impact factor: 2.584
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.